$IART
Integra Lifesciences Holdings Corp

2015 Q1 Form 10-Q Financial Statement

#000091752015000022 Filed on May 01, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1
Revenue $202.5M $215.1M
YoY Change -5.82% 9.36%
Cost Of Revenue $75.22M $82.38M
YoY Change -8.69% 3.48%
Gross Profit $127.3M $112.6M
YoY Change 13.11% -3.83%
Gross Profit Margin 62.86% 52.34%
Selling, General & Admin $93.27M $108.3M
YoY Change -13.91% 5.22%
% of Gross Profit 73.26% 96.25%
Research & Development $11.08M $12.57M
YoY Change -11.84% -1.17%
% of Gross Profit 8.7% 11.17%
Depreciation & Amortization $11.80M $13.96M
YoY Change -15.48% 22.58%
% of Gross Profit 9.27% 12.4%
Operating Expenses $104.3M $120.9M
YoY Change -13.7% 4.52%
Operating Profit $21.24M $8.738M
YoY Change 143.08% -499.0%
Interest Expense $5.472M $5.142M
YoY Change 6.42% 7.13%
% of Operating Profit 25.76% 58.85%
Other Income/Expense, Net $2.017M $317.0K
YoY Change 536.28% -132.55%
Pretax Income $17.79M $3.975M
YoY Change 347.55% -150.31%
Income Tax $6.058M $1.769M
% Of Pretax Income 34.05% 44.5%
Net Earnings $8.384M $2.206M
YoY Change 280.05% -136.6%
Net Earnings / Revenue 4.14% 1.03%
Basic Earnings Per Share $0.13 $0.07
Diluted Earnings Per Share $0.13 $0.07
COMMON SHARES
Basic Shares Outstanding 32.74M shares 32.28M shares
Diluted Shares Outstanding 33.34M shares 32.77M shares

Balance Sheet

Concept 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $79.90M $129.0M
YoY Change -38.06% 43.81%
Cash & Equivalents $79.87M $129.0M
Short-Term Investments
Other Short-Term Assets $82.30M $83.00M
YoY Change -0.84% 25.95%
Inventory $233.0M $215.2M
Prepaid Expenses
Receivables $126.8M $112.5M
Other Receivables $0.00 $0.00
Total Short-Term Assets $522.0M $539.7M
YoY Change -3.3% 20.73%
LONG-TERM ASSETS
Property, Plant & Equipment $210.1M $205.7M
YoY Change 2.16% 14.67%
Goodwill $354.2M $367.6M
YoY Change -3.66% 25.79%
Intangibles $447.4M $429.4M
YoY Change 4.19% 102.31%
Long-Term Investments
YoY Change
Other Assets $11.44M $7.770M
YoY Change 47.18% -20.59%
Total Long-Term Assets $1.029B $1.016B
YoY Change 1.25% 43.24%
TOTAL ASSETS
Total Short-Term Assets $522.0M $539.7M
Total Long-Term Assets $1.029B $1.016B
Total Assets $1.551B $1.556B
YoY Change -0.33% 34.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $42.60M $46.40M
YoY Change -8.19% 5.69%
Accrued Expenses $41.04M $37.70M
YoY Change 8.87% 9.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $5.600M
YoY Change
Total Short-Term Liabilities $126.8M $116.8M
YoY Change 8.54% 10.45%
LONG-TERM LIABILITIES
Long-Term Debt $611.4M $629.0M
YoY Change -2.8% 20.64%
Other Long-Term Liabilities $32.05M $36.28M
YoY Change -11.67% 158.42%
Total Long-Term Liabilities $32.05M $36.28M
YoY Change -11.67% 158.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $126.8M $116.8M
Total Long-Term Liabilities $32.05M $36.28M
Total Liabilities $862.7M $876.7M
YoY Change -1.6% 35.59%
SHAREHOLDERS EQUITY
Retained Earnings $323.3M $283.2M
YoY Change 14.19% -4.97%
Common Stock $779.5M $761.2M
YoY Change 2.4% 28.95%
Preferred Stock
YoY Change
Treasury Stock (at cost) $367.1M $367.1M
YoY Change 0.0% 0.0%
Treasury Stock Shares 8.903M shares 8.903M shares
Shareholders Equity $688.1M $679.2M
YoY Change
Total Liabilities & Shareholders Equity $1.551B $1.556B
YoY Change -0.33% 34.54%

Cashflow Statement

Concept 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income $8.384M $2.206M
YoY Change 280.05% -136.6%
Depreciation, Depletion And Amortization $11.80M $13.96M
YoY Change -15.48% 22.58%
Cash From Operating Activities $31.62M $11.25M
YoY Change 180.96% 43.44%
INVESTING ACTIVITIES
Capital Expenditures $5.330M $11.34M
YoY Change -52.98% 4.44%
Acquisitions $0.00 $235.0M
YoY Change -100.0% 8396.02%
Other Investing Activities $3.300M -$235.0M
YoY Change -101.4% 10581.82%
Cash From Investing Activities -$5.632M -$246.3M
YoY Change -97.71% 1782.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$13.83M $243.2M
YoY Change -105.69% 94520.23%
NET CHANGE
Cash From Operating Activities $31.62M $11.25M
Cash From Investing Activities -$5.632M -$246.3M
Cash From Financing Activities -$13.83M $243.2M
Net Change In Cash $12.16M $8.093M
YoY Change 50.27% -262.38%
FREE CASH FLOW
Cash From Operating Activities $31.62M $11.25M
Capital Expenditures $5.330M $11.34M
Free Cash Flow $26.29M -$81.00K
YoY Change -32555.56% -97.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 iart Proceedsfrom Working Capital Adjustment
ProceedsfromWorkingCapitalAdjustment
0 USD
CY2015Q1 iart Proceedsfrom Working Capital Adjustment
ProceedsfromWorkingCapitalAdjustment
1831000 USD
CY2015Q1 iart Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill
CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
633026000 USD
CY2014Q4 iart Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill
DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
459459000 USD
CY2015Q1 iart Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill
DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill
447424000 USD
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000917520
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32934413 shares
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
INTEGRA LIFESCIENCES HOLDINGS CORP
CY2015Q1 dei Trading Symbol
TradingSymbol
iart
CY2013Q4 iart Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedge Effect Before Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgeEffectBeforeTax
-2439000 USD
CY2014Q1 iart Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedge Effect Before Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgeEffectBeforeTax
-2097000 USD
CY2014Q4 iart Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedge Effect Before Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgeEffectBeforeTax
-898000 USD
CY2015Q1 iart Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedge Effect Before Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgeEffectBeforeTax
-527000 USD
CY2014Q4 iart Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill
CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill
639648000 USD
CY2015Q1 iart Termloanamountoutstanding
Termloanamountoutstanding
150000000 USD
CY2014Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
34060000 USD
CY2015Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
42630000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
131918000 USD
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126785000 USD
CY2014Q1 us-gaap Accretion Expense
AccretionExpense
1666000 USD
CY2015Q1 us-gaap Accretion Expense
AccretionExpense
1859000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42096000 USD
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41038000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23488000 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-47616000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
779555000 USD
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
779074000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6184000 USD
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6515000 USD
CY2014Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
608000 USD
CY2015Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
530000 USD
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3033000 USD
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3535000 USD
CY2014Q4 us-gaap Assets
Assets
1578625000 USD
CY2015Q1 us-gaap Assets
Assets
1550807000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
529321000 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
521950000 USD
CY2015Q1 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.17
CY2015Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
5572000 USD
CY2015Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
225509000 USD
CY2014Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
128000 USD
CY2015Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
125000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120614000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
129038000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71994000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
79871000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8424000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7877000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41644000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41755000 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
416000 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
418000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3206000 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15744000 USD
CY2014Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
213121000 USD
CY2015Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
215177000 USD
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
82383000 USD
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
86722000 USD
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
206321000 USD
CY2015Q1 us-gaap Costs And Expenses
CostsAndExpenses
216877000 USD
CY2014Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1563000 USD
CY2015Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1184000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5176000 USD
CY2015Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4303000 USD
CY2015Q1 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-18000 USD
CY2014Q1 us-gaap Derivative Net Hedge Ineffectiveness Gain Loss
DerivativeNetHedgeIneffectivenessGainLoss
0 USD
CY2015Q1 us-gaap Derivative Net Hedge Ineffectiveness Gain Loss
DerivativeNetHedgeIneffectivenessGainLoss
0 USD
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2014Q1 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-109000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
58663000 USD
CY2015Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
58293000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
5603000 USD
CY2015Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
5684000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
91623000 USD
CY2015Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
92431000 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13961000 USD
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15414000 USD
CY2015Q1 us-gaap Derivative Description Of Terms
DerivativeDescriptionOfTerms
August 10, 2015
CY2014Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
898000 USD
CY2015Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
527000 USD
CY2014Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-451000 USD
CY2015Q1 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-389000 USD
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
331000 USD
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-4284000 USD
CY2014Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.445
CY2015Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.335
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
40943000 USD
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33209000 USD
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
541000 USD
CY2015Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1121000 USD
CY2014Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
541000 USD
CY2015Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1121000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
180189000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
185602000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
29600000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
31800000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
26500000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
27200000 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
27600000 USD
CY2014Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2015Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
19000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
363888000 USD
CY2015Q1 us-gaap Goodwill
Goodwill
354202000 USD
CY2014Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
600000 USD
CY2015Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
409000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3975000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
12617000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1769000 USD
CY2015Q1 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
36009000 USD
CY2015Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
53168000 USD
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
50166000 USD
CY2015Q1 us-gaap Inventory Net
InventoryNet
233043000 USD
CY2014Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
36465000 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4233000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4438000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1885000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5671000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2100000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
21000 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-769000 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8516000 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2789000 USD
CY2014Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2437000 USD
CY2015Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1547000 USD
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
127000 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1730000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1582000 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6003000 USD
CY2014Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2015Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
30000 shares
CY2014Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
493000 shares
CY2015Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
576000 shares
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
459459000 USD
CY2015Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
447424000 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
5142000 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
5492000 USD
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
150483000 USD
CY2015Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
143866000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
237114000 USD
CY2014Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
62000 USD
CY2015Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
874303000 USD
CY2015Q1 us-gaap Liabilities
Liabilities
862708000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1578625000 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1550807000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
126025000 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
126805000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
243174000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13826000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-246335000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5632000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11254000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31619000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
2206000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
8384000 USD
CY2015Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segment
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
8738000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
16788000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10368000 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11436000 USD
CY2014Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-14000 USD
CY2015Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
54000 USD
CY2014Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
819000 USD
CY2015Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-24393000 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-24349000 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-24128000 USD
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
195000 USD
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
211000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
30409000 USD
CY2015Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32045000 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
317000 USD
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1316000 USD
CY2014Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
235000000 USD
CY2015Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11335000 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8901000 USD
CY2014Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2015Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29632000 USD
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23958000 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
235000000 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 USD
CY2014Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2015Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1438000 USD
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7755000 USD
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
231000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
209986000 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
210111000 USD
CY2015Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-221000 USD
CY2014Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
122000 USD
CY2015Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
178000 USD
CY2014Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 USD
CY2015Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
15000000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12567000 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12556000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
314960000 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
323344000 USD
CY2014Q1 us-gaap Revenues
Revenues
215059000 USD
CY2015Q1 us-gaap Revenues
Revenues
233665000 USD
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
215059000 USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
233665000 USD
CY2014Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
3750000 USD
CY2015Q1 us-gaap Secured Debt Current
SecuredDebtCurrent
5625000 USD
CY2014Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
413125000 USD
CY2015Q1 us-gaap Secured Long Term Debt
SecuredLongTermDebt
396250000 USD
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
108338000 USD
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
114064000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2471000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2377000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P3Y
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
78336 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1400000 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1300000 shares
CY2015Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
75000000 USD
CY2014Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2015Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
704322000 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
688099000 USD
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
8903000 shares
CY2015Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
8903000 shares
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
367121000 USD
CY2015Q1 us-gaap Treasury Stock Value
TreasuryStockValue
367121000 USD
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32768000 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33342000 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32275000 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32736000 shares

Files In Submission

Name View Source Status
0000917520-15-000022-index-headers.html Edgar Link pending
0000917520-15-000022-index.html Edgar Link pending
0000917520-15-000022.txt Edgar Link pending
0000917520-15-000022-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
iart-20150331.xml Edgar Link completed
iart-20150331.xsd Edgar Link pending
iart-20150331x10q.htm Edgar Link pending
iart-20150331xex101.htm Edgar Link pending
iart-20150331xex102.htm Edgar Link pending
iart-20150331xex103.htm Edgar Link pending
iart-20150331xexx311.htm Edgar Link pending
iart-20150331xexx312.htm Edgar Link pending
iart-20150331xexx321.htm Edgar Link pending
iart-20150331xexx322.htm Edgar Link pending
iart-20150331_cal.xml Edgar Link unprocessable
iart-20150331_def.xml Edgar Link unprocessable
iart-20150331_lab.xml Edgar Link unprocessable
iart-20150331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending